Mamonta, Mejolyn C.
HRN: 26-05-43 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2025
CEFTRIAXONE 1G (VIAL)
05/28/2025
06/03/2025
IV
2g
OD
Appendicitis
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines